Cargando…

PIN44 Benefit Design Considerations during Emergencies: Lessons from Covid 19

Detalles Bibliográficos
Autores principales:	Panelo, C.I., Tan, C., Nachura, S., Pargas, I.F., Santillan, M., Sugay, N., Moreno, A., Miradora, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2020
Materias:	Infectious Diseases - Health Policy & Regulatory
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487860/ http://dx.doi.org/10.1016/j.vhri.2020.07.291

Ejemplares similares

PIN54 Analysis of COVID-19 Treatment Drugs Availability in Ukraine
por: Blavatska, O., et al.
Publicado: (2021)

PIN42 Current Trends in Covid-19 Testing Rates and Unmet NEEDS
por: Sethi, A., et al.
Publicado: (2020)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Evaluation of reoperations for removal of bioabsorbable plates and screws based on adverse events reports from PMDA, Japan
por: Kobayashi, Tomoko, et al.
Publicado: (2020)

Joint effort: a call for standardization in total joint arthroplasty data reporting
por: Liebeskind, Alexander Y, et al.
Publicado: (2021)

Coronavirus disease 2019: International public health considerations
por: Greene, Christopher J., et al.
Publicado: (2020)

Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

COVID‐19 in Seattle—Early lessons learned
por: Miller, Gregg A., et al.
Publicado: (2020)

Lecythophora Soft-Tissue Infection: Case Report and Treatment Considerations
por: Golden, Ryan, et al.
Publicado: (2023)

Adenoviral Infections in Bone Marrow Transplanted Adult Patients: A Review of the 44 Cases Reported in the Last 25 Years
por: Keramari, Stergiani, et al.
Publicado: (2021)

The Fragile Patient: Considerations in the Management of Invasive Mould Infections (IMIs) in India
por: Kundu, Prithwijit, et al.
Publicado: (2023)

Lessons learned from COVID‐19 outbreak in a skilled nursing facility, Washington State
por: Morris, Stephen C., et al.
Publicado: (2020)

Patients Follow-up for Spinal Epidural Abscess as a Critical Treatment Plan Consideration
por: MacNeille, Rhett, et al.
Publicado: (2023)

Phenotypic and Genotypic Correlation of Antimicrobial Susceptibility of Bacteroides fragilis: Lessons Learnt
por: Jha, Lisha, et al.
Publicado: (2023)

Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal
por: Chapagain, Ram Hari, et al.
Publicado: (2023)

Routine Preoperative Dental Clearance for Total Joint Arthroplasty: Is There a Benefit?
por: Kwan, Stephanie A, et al.
Publicado: (2023)

Lessons Learned From a Case of Behcet’s Disease Presenting With Fever and Life-Threatening Venous Thromboembolism
por: Conlon, Peter, et al.
Publicado: (2022)

PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients
por: Mori, T.
Publicado: (2020)

PIN62 Recognising the broader value of vaccines in HTA: ready for prime time?
por: Brassel, S., et al.
Publicado: (2021)

Lessons learnt from the first wave of COVID-19 in Damascus, Syria: a multicentre retrospective cohort study
por: Hanafi, Ibrahem, et al.
Publicado: (2023)

Rapid Point-of-Care Influenza Testing for Patients in German Emergency Rooms – A Cost-Benefit Analysis
por: Diel, Roland, et al.
Publicado: (2019)

COVID‐19 and beyond: Lessons learned from emergency department HIV screening for population‐based screening in healthcare settings
por: Faryar, Kiran A., et al.
Publicado: (2021)

Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis
por: Holland, Thomas L, et al.
Publicado: (2016)

Knowledge of Human Papillomavirus, Risk of Anogenital Cancers, and Benefits of Vaccination: A Medical Student Survey in Saudi Arabia
por: Almutairi, Salman N, et al.
Publicado: (2019)

A teenager with fever, chest pain, and respiratory distress during the coronavirus disease 2019 pandemic: a lesson on anchoring bias
por: Karn, Michele N., et al.
Publicado: (2020)

Measles cases in Split-Dalmatia County (a Croatian tourist region), in May–July 2019: outbreak report and lessons learnt
por: Brzovic, Milka, et al.
Publicado: (2022)

Targeted Sanger Sequencing of a Cluster of COVID-19 Cases in the Surgical ICU of a Non-COVID Hospital: Lessons Learned
por: Embekkat Kaviyil, Jyothi, et al.
Publicado: (2023)

Cluster-randomised controlled trials of individual and combined water, sanitation, hygiene and nutritional interventions in rural Bangladesh and Kenya: the WASH Benefits study design and rationale
por: Arnold, Benjamin F, et al.
Publicado: (2013)

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis
por: Padula, W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0t564e1096u6epspstjh98bs1j